跳至主要内容
临床试验/ISRCTN15078551
ISRCTN15078551进行中(未招募)Unknown

Comparative efficacy and safety of upadacitinib versus oral prednisolone for the induction and maintenance of remission in moderate to severe ulcerative colitis: a prospective, multicenter, open-label, randomised controlled trial (PREDUPA Trial)

Ministry of Health Kuwait0 个研究点目标入组 100 人开始时间: 2024年3月13日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1.Males + Females with moderate-to-severe UC
  • 2.Age 18 – 60 years
  • 3.All durations of disease
  • 4.All extents of disease (proctitis / left-sided colitis / pancolitis)
  • 5.Previously failed to respond to conventional therapies and/or anti-TNF therapy
  • 6.Biologic-naïve
  • 7.On a stable dose of 5-ASA or immunomodulator four weeks prior to the start of the study

排除标准

  • 1.Pregnant / lactating
  • 2.Crohn’s colitis
  • 3.Latent or active TB
  • 4.Active infection
  • 5.Current or past malignancy
  • 6.Active or past thromboembolic disease

研究者

相似试验